Search

everythinglearnresearchcommunity

for

Search:↓

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Minoxidil helps hair regrowth in alopecia areata safely.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The Mason gastric bypass is a better surgery for weight loss with fewer complications compared to other methods.

Oral contraceptives may cause hair loss in women.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.